Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-16T17:30:42.922Z Has data issue: false hasContentIssue false
  • English
  • Français

Age-dependent effects of milrinone and levosimendan on ventricular function and haemodynamics in newborn and mature pigs

Published online by Cambridge University Press:  10 May 2011

Janus A. Hyldebrandt ,
Signe H. Larsen ,
Michael R. Schmidt ,
Vibeke E. Hjortdal  and
Hanne B. Ravn
Janus A. Hyldebrandt*
Affiliation:
Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Skejby, Aarhus N, Denmark Institute of Clinical Medicine, Aarhus University Hospital, Skejby, Aarhus N, Denmark
Signe H. Larsen
Affiliation:
Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby, Aarhus N, Denmark
Michael R. Schmidt
Affiliation:
Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus N, Denmark
Vibeke E. Hjortdal
Affiliation:
Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby, Aarhus N, Denmark
Hanne B. Ravn
Affiliation:
Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Skejby, Aarhus N, Denmark
*
Correspondence to: J. A. Hyldebrandt MD, Department of Anesthesiology and Intensive Care, Aarhus University Hospital Skejby, 8200 Aarhus N, Denmark. Tel: +45 21210204; Fax: +45 89498750; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Inodilators are used in the treatment of low cardiac output, mainly after cardiac surgery. At present, there is little knowledge of the effect of inodilators in the newborn heart. Immediately after birth and in the neonatal period, the metabolism and physiology of the heart undergo major changes. We hypothesised that effects of the inodilators milrinone and levosimendan on myocardial contractility and haemodynamics under normal physiological conditions were age dependent. Animal studies were conducted on 48 pigs using a closed-chest biventricular conductance catheter method. Pigs in two age groups, that is, 5–6 days and 5–6 weeks, were assigned to milrinone, levosimendan, or a control group. We observed that both milrinone – 19.2% with a p value of 0.05 – and levosimendan – 25.7% with a p value of 0.03 compared with the control group increased cardiac output, as well as myocardial contractility with a maximum pressure development over time: milrinone 28.2%, p = 0.01 and levosimendan 19.4%, p = 0.05. Milrinone improved diastolic performance (p < 0.05) in the left ventricle in the 5–6-week-old animals. In the newborn animals, neither of the inodilators increased ventricular contractility or cardiac output; however, we observed a significant decrease in the mean arterial pressure: milrinone 34.6%, p < 0.01 and levosimendan 30.1%, p = 0.02. Both inodilators demonstrated age-dependent haemodynamic effects, and it is noteworthy that neither milrinone nor levosimendan was able to increase cardiac output in the newborn heart.

Keywords

Levosimendanmilrinonecardiac outputlowinfantnewbornhaemodynamicsmyocardial contraction
Type
Original Articles
Information
Cardiology in the Young , Volume 21 , Issue 5 , 09 September 2011 , pp. 518 - 527
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hoffman, TM, Wernovsky, G, Atz, AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996–1002.CrossRefGoogle ScholarPubMed
2.Bailey, JM, Miller, BE, Lu, W, et al. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999; 90: 1012–1018.CrossRefGoogle ScholarPubMed
3.Stocker, CF, Shekerdemian, LS, Norgaard, MA, et al. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Crit Care Med 2007; 35: 252–259.CrossRefGoogle Scholar
4.Follath, F, Cleland, JG, Just, H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196–202.CrossRefGoogle ScholarPubMed
5.Caspi, J, Coles, JG, Benson, LN, et al. Heart rate independence of catecholamine-induced myocardial damage in the newborn pig. Pediatr Res 1994; 36: 49–54.CrossRefGoogle ScholarPubMed
6.Fowler, MB, Alderman, EL, Oesterle, SN, et al. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine. Circulation 1984; 70: I103–I111.Google ScholarPubMed
7.Wittnich, C, Belanger, MP, Bandali, K. Are there ventricle-specific postnatal maturational differences in myocardial beta-adrenoceptors? Can J Physiol Pharmacol 2006; 84: 859–865.CrossRefGoogle ScholarPubMed
8.Tanaka, H, Shigenobu, K. Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart. Br J Pharmacol 1990; 100: 138–142.CrossRefGoogle ScholarPubMed
9.Shaddy, RE, Tyndall, MR, Teitel, DF, Li, C, Rudolph, AM. Regulation of cardiac output with controlled heart rate in newborn lambs. Pediatr Res 1988; 24: 577–582.CrossRefGoogle ScholarPubMed
10.Paradisis, M, Evans, N, Kluckow, M, Osborn, D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr 2009; 154: 189–195.CrossRefGoogle ScholarPubMed
11.Egan, JR, Clarke, AJ, Williams, S, et al. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med 2006; 21: 183–187.CrossRefGoogle ScholarPubMed
12.Namachivayam, P, Crossland, DS, Butt, WW, Shekerdemian, LS. Early experience with levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med 2006; 7: 445–448.CrossRefGoogle ScholarPubMed
13.Baan, J, van der Velde, ET, de Bruin, HG, et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 1984; 70: 812–823.CrossRefGoogle ScholarPubMed
14.Weiss, JL, Frederiksen, JW, Weisfeldt, ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976; 58: 751–760.CrossRefGoogle ScholarPubMed
15.Glower, DD, Spratt, JA, Snow, ND, et al. Linearity of the Frank–Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 1985; 71: 994–1009.CrossRefGoogle ScholarPubMed
16.Segreti, JA, Marsh, KC, Polakowski, JS, Fryer, RM. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure. J Pharmacol Exp Ther 2008; 325: 331–340.CrossRefGoogle Scholar
17.Banfor, PN, Preusser, LC, Campbell, TJ, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol 2008; 294: H238–H248.CrossRefGoogle ScholarPubMed
18.Bailey, JM, Hoffman, TM, Wessel, DL, et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn 2004; 31: 43–59.CrossRefGoogle ScholarPubMed
19.Feneck, RO. Milrinone and postoperative pulmonary hypertension. J Cardiothorac Vasc Anesth 1993; 7: 21–23.CrossRefGoogle ScholarPubMed
20.Chang, AC, Atz, AM, Wernovsky, G, Burke, RP, Wessel, DL. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907–1914.CrossRefGoogle ScholarPubMed
21.Sys, SU, Goenen, MJ, Chalant, CH, Brutsaert, DL. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle. Circulation 1986; 73: III25–III35.Google ScholarPubMed
22.Leather, HA, Ver, EK, Segers, P, et al. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med 2003; 31: 2339–2343.CrossRefGoogle ScholarPubMed
23.Binah, O, Legato, MJ, Danilo, P Jr, Rosen, MR. Developmental changes in the cardiac effects of amrinone in the dog. Circ Res 1983; 52: 747–752.CrossRefGoogle ScholarPubMed
24.Klitzner, TS, Shapir, Y, Ravin, R, Friedman, WF. The biphasic effect of amrinone on tension development in newborn mammalian myocardium. Pediatr Res 1990; 27: 144–147.CrossRefGoogle ScholarPubMed
25.Ross-Ascuitto, N, Ascuitto, R, Chen, V, Downing, SE. Negative inotropic effects of amrinone in the neonatal piglet heart. Circ Res 1987; 61: 847–852.CrossRefGoogle ScholarPubMed
26.Ross-Ascuitto, NT, Ascuitto, RJ, Ramage, D, McDonough, KH. The effects of milrinone in the neonatal pig heart. Cardiovasc Drugs Ther 1991; 5: 1011–1019.CrossRefGoogle ScholarPubMed
27.Binah, O, Sodowick, B, Vulliemoz, Y, Danilo, P Jr, Rosen, M. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Circulation 1986; 73: III46–III51.Google Scholar
28.Akita, T, Joyner, RW, Lu, C, Kumar, R, Hartzell, HC. Developmental changes in modulation of calcium currents of rabbit ventricular cells by phosphodiesterase inhibitors. Circulation 1994; 90: 469–478.CrossRefGoogle ScholarPubMed
29.Seguchi, M, Harding, JA, Jarmakani, JM. Developmental change in the function of sarcoplasmic reticulum. J Mol Cell Cardiol 1986; 18: 189–195.CrossRefGoogle ScholarPubMed
30.Lechner, E, Moosbauer, W, Pinter, M, Mair, R, Tulzer, G. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatr Crit Care Med 2006; 8: 61–63.CrossRefGoogle Scholar
31.Feneck, RO, Sherry, KM, Withington, PS, Oduro-Dominah, A. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15: 306–315.CrossRefGoogle ScholarPubMed
32.Joynt, C, Bigam, DL, Charrois, G, et al. Dose-response effects of milrinone on hemodynamics of newborn pigs with hypoxia-reoxygenation. Intensive Care Med 2008; 34: 1321–1329.CrossRefGoogle ScholarPubMed